Cargando…

Emerging Insights into Molecular Mechanisms of Inflammation in Myelodysplastic Syndromes

Inflammation impacts human hematopoiesis across physiologic and pathologic conditions, as signals derived from the bone marrow microenvironment, such as pro-inflammatory cytokines and chemokines, have been shown to alter hematopoietic stem cell (HSCs) homeostasis. Dysregulated inflammation can skew...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vallelonga, Veronica, Gandolfi, Francesco, Ficara, Francesca, Della Porta, Matteo Giovanni, Ghisletti, Serena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603842/ https://www.ncbi.nlm.nih.gov/pubmed/37892987 http://dx.doi.org/10.3390/biomedicines11102613

Ejemplares similares

Importance of Classical Morphology in the Diagnosis of Myelodysplastic Syndrome
por: Invernizzi, Rosangela, et al.
Publicado: (2015)

The Genetics of Myelodysplastic Syndromes: Clinical Relevance
por: Chiereghin, Chiara, et al.
Publicado: (2021)

Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes
por: Della Porta, Matteo G., et al.
Publicado: (2017)

Novel insights into the role of acetyl-CoA producing enzymes in epigenetic regulation
por: Russo, Marta, et al.
Publicado: (2023)

Emerging Therapies for the Myelodysplastic Syndromes
por: Canaani, Jonathan
Publicado: (2019)

Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes
por: Sauta, Elisabetta, et al.
Publicado: (2023)

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
por: Malcovati, Luca, et al.
Publicado: (2011)

Molecular and Cellular Mechanisms of Myelodysplastic Syndrome: Implications on Targeted Therapy
por: Gill, Harinder, et al.
Publicado: (2016)

Molecular Pathogenesis of Myelodysplastic Syndromes
por: Visconte, Valeria, et al.
Publicado: (2014)

Targeting age-related inflammation in myelodysplastic syndromes
por: Mei, Yang, et al.
Publicado: (2018)

Immune Mechanisms in Myelodysplastic Syndrome
por: Glenthøj, Andreas, et al.
Publicado: (2016)

Myelodysplastic syndromes: advantages of a combined cytogenetic and molecular diagnostic workup
por: Ciabatti, Elena, et al.
Publicado: (2017)

Molecular Pathogenesis and Treatment of Myelodysplastic Syndromes
por: Nakajima, Hideaki
Publicado: (2020)

Optimal timing of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome
por: Alessandrino, Emilio Paolo, et al.
Publicado: (2013)

Mechanisms of Resistance to Decitabine in the Myelodysplastic Syndrome
por: Qin, Taichun, et al.
Publicado: (2011)

Patient and Caregiver Insights into the Disease Burden of Myelodysplastic Syndrome
por: Soper, John, et al.
Publicado: (2022)

Magnesium in Obesity, Metabolic Syndrome, and Type 2 Diabetes
por: Piuri, Gabriele, et al.
Publicado: (2021)

Clinical and Molecular Insights in Erythropoiesis Regulation of Signal Transduction Pathways in Myelodysplastic Syndromes and β-Thalassemia
por: Parisi, Sarah, et al.
Publicado: (2021)

Molecular Targeted Therapy and Immunotherapy for Myelodysplastic Syndrome
por: Lee, Paul, et al.
Publicado: (2021)

Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms
por: Romano, Michela, et al.
Publicado: (2017)

Cytogenetic study in therapy-related myelodysplastic syndromes (t-MDS) and acute non-lymphocytic leukaemia (t-ANLL).
por: Sozzi, G., et al.
Publicado: (1990)

Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes
por: Bersanelli, Matteo, et al.
Publicado: (2021)

Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes
por: Gerstung, Moritz, et al.
Publicado: (2015)

New Treatments for Myelodysplastic Syndromes
por: D’Alò, Francesco, et al.
Publicado: (2010)

Myelodysplastic Syndromes Diagnosis: What Is the Role of Molecular Testing?
por: Bejar, Rafael
Publicado: (2015)

Molecular features of early onset adult myelodysplastic syndrome
por: Hirsch, Cassandra M., et al.
Publicado: (2017)

Myelodysplastic syndromes
por: Hellström Lindberg, Eva
Publicado: (2018)

Emerging treatment options for patients with high-risk myelodysplastic syndrome
por: Bewersdorf, Jan Philipp, et al.
Publicado: (2020)

Emerging treatments for myelodysplastic syndromes: Biological rationales and clinical translation
por: Rodriguez-Sevilla, Juan Jose, et al.
Publicado: (2023)

Age-related diseases of inflammation in myelodysplastic syndrome and chronic myelomonocytic leukemia
por: Weeks, Lachelle D., et al.
Publicado: (2022)

Pathogenesis of myelodysplastic syndromes: an overview of molecular and non-molecular aspects of the disease
por: Visconte, Valeria, et al.
Publicado: (2014)

Bilateral Adrenal Hemorrhage in a Patient with Myelodysplastic Syndrome: Value of MRI in the Differential Diagnosis
por: Manganaro, Lucia, et al.
Publicado: (2013)

Senescent Mesenchymal Stem Cells in Myelodysplastic Syndrome: Functional Alterations, Molecular Mechanisms, and Therapeutic Strategies
por: Chen, Xiaofang, et al.
Publicado: (2021)

Genetics and Epigenetics of Myelodysplastic Syndromes and Response to Drug Therapy: New Insights
por: Shahrabi, Saeid, et al.
Publicado: (2016)

Editorial: Risk-stratification in myelodysplastic syndromes
por: Breccia, Massimo, et al.
Publicado: (2022)

PBX1-directed stem cell transcriptional program drives tumor progression in myeloproliferative neoplasm
por: Muggeo, Sharon, et al.
Publicado: (2021)

PB2672: EXPLORING UNMET NEEDS OF PATIENTS WITH MYELODYSPLASTIC NEOPLASMS AND CAREGIVERS IN A NATIONAL ITALIAN SURVEY
por: Crisà, Elena, et al.
Publicado: (2023)

PB2026: ROLE OF MOLECULAR PROFILING IN MYELODYSPLASTIC SYNDROME IN REAL-WORLD - A NEW APPROACH IN MYELODYSPLASTIC SYNDROME’S RISK STRATIFICATION?
por: Silva, Duarte Pacheco, et al.
Publicado: (2023)

Molecular dissection of engraftment in a xenograft model of myelodysplastic syndromes
por: Meunier, Mathieu, et al.
Publicado: (2018)

Molecular and cytogenetic characterization of myelodysplastic syndromes in cell-free DNA
por: Garcia-Gisbert, Nieves, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c9gdtq3o5d86oqjn8j499jtrnv